% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • marketman9876 marketman9876 Apr 27, 2013 9:58 AM Flag

    Motley Fool artice shows what FOOLS they are, as they miss the point

    They are talking about profits, lack thereof and narrowing the loss as, they say, is expected by analysts.

    Cytokinetics is not here to make a profit at this juncture, but to get the pipeline onto pharmacy shelves, and to continue to R&D for more pipeline candidates.

    When heart muscle contractility is improved by CYTK, the word won't be profit....the word will be HUUUGE.

    Buying then will be a LOT more expensive than it is now.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Either they P&D big time or they have some of the worst investment picks I've seen. Examples: AAPL, PKD, TC, MUX, DVN, DDD, and so many others. All I know is I had several stocks they pumped like crazy, only to have them crater after earnings. Schwab told me there investment analysis is more long term. They said a year. I called them back in a year and told them there information was a failure last year and even worse now.

    • Motley fools is not trying to tell us anything about cyto. They are alwasy trying to sell their service. You will notice they often mention two or three widely held companies in the article so that it appears in the news of those comapnies too All the coverage seems sponsored.

    • I see CYTK making a paragraph on next weeks highlights MF as a positive development, we are alongside some here nice companies in that article. Also, if readers check out the pipeline they will be surprised to see that there is more diversity than stated. There are other drugs besides MO, and with near term catalysts. Another buying opportunity for CYTK with a lower SP around CC is very attractive. I haven't sold a share yet.

      Sentiment: Strong Buy

8.15+0.04(+0.49%)May 31 4:00 PMEDT